Study of Brenipatide for adults with schizophrenia
Treatments studied
Part of Mental health clinical trials.
This trial tests an investigational drug called brenipatide for people with schizophrenia who are already on a stable medication regimen. The goal is to see if adding this drug helps reduce relapses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with schizophrenia.
- You are on a stable dose of your current schizophrenia medication.
- If you've had schizophrenia for more than 6 years, you must have had at least one relapse in the last 3 years.
- You have a reliable study partner (like a family member, social worker, or nurse) who can help support you during the study.
- You are willing to self-inject the study drug, keep a diary, and fill out questionnaires.
- You do not have a history of bipolar disorder, borderline personality disorder, or eating disorder.
- You do not have moderate or severe alcohol or drug use problems in the past 6 months.
- You do not have type 1 diabetes, or a history of diabetic coma or ketoacidosis.
- You are not actively suicidal or at high risk for suicide.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an investigational medicine called NBI-1117568 in adults with schizophrenia who are currently having a relapse or worsening of symptoms and need to stay in the hospital. The goal is to see if the medicine is safe and effective.
This study tests a new medicine called NBI-1117568 for adults with schizophrenia over a longer period of time. Participants will stop their current antipsychotics and take this new drug to see how well it works and how safe it is.
This study tests an experimental drug (NBI-1117568) for people with schizophrenia who are currently in the hospital due to worsening symptoms. Participants stop their current antipsychotic and take the study drug to see if it can help control symptoms.
This trial tests a new medicine, NBI-1117568, to see if it can help prevent a relapse of schizophrenia symptoms. It is for adults who have been stable on other antipsychotics and want to avoid returning to the hospital for a psychiatric stay.
This study tests an experimental medication (NBI-1117570) for adults with schizophrenia who are currently in the hospital because of a sudden worsening of symptoms. The goal is to see if this new treatment can help control symptoms better.
This trial tests a new medication called SEP-363856 over a long period for people with schizophrenia who are currently stable. It looks at how well the drug works and its safety over time.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.